Amphastar Pharmaceuticals Ownership | Who Owns Amphastar Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amphastar Pharmaceuticals Ownership Summary


Amphastar Pharmaceuticals is owned by 68.20% institutional investors, 29.63% insiders, and 2.17% retail investors. Blackrock is the largest institutional shareholder, holding 12.33% of AMPH shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.86% of its assets in Amphastar Pharmaceuticals shares.

AMPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmphastar Pharmaceuticals68.20%29.63%2.17%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.94M12.33%$237.70M
Blackrock funding, inc. /de5.42M11.60%$106.20M
Vanguard group2.61M5.61%$69.85M
Dimensional fund advisors lp2.03M4.34%$39.73M
State street1.61M3.44%$31.49M
Td asset management1.54M3.30%$30.19M
Fuller & thaler asset management1.40M2.98%$27.33M
Marshall wace, llp1.03M2.19%$20.09M
American century companies1.02M2.18%$19.93M
Geode capital management976.65K2.09%$19.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bridge city capital335.11K1.82%$6.56M
Lam group130.80K1.41%$2.56M
Mesirow institutional investment management380.39K1.09%$14.12M
Denali advisors266.46K0.58%$5.22M
Illumine investment management28.08K0.42%$550.05K
Summerhaven investment management32.63K0.39%$639.28K
Nverses capital17.68K0.31%$346.45K
Hussman strategic advisors63.00K0.27%$1.23M
Rice hall james & associates187.35K0.20%$3.67M
Systematic financial management lp452.90K0.20%$8.87M

Top Buyers

HolderShares% AssetsChange
Lsv asset management651.71K0.03%541.41K
American century companies1.02M0.01%352.20K
Vanguard fiduciary trust231.04K0.00%231.04K
Dimensional fund advisors lp2.03M0.01%228.26K
Ubs group420.26K0.00%163.64K

Top Sellers

HolderShares% AssetsChange
Neuberger berman group---1.37M
Boston partners---423.07K
Td asset management1.54M0.02%-422.01K
Hotchkis & wiley capital management---402.56K
Granite investment partners---375.78K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust231.04K0.00%231.04K$4.53M
Brandywine global investment management105.42K0.02%105.42K$2.82M
Robeco institutional asset management b.v.66.41K0.00%66.41K$1.30M
Hussman strategic advisors63.00K0.27%63.00K$1.23M
Vanguard global advisers50.16K0.00%50.16K$982.69K

Sold Out

HolderChange
Sjs investment consulting-1.00
Financial gravity asset management-1.00
Caitong asset management-3.00
Jfs wealth advisors-3.00
Wealthtrak capital management-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026210-11.02%31,878,295-5.06%681.31%98-16.24%88-
Dec 31, 202576-68.98%5,515,721-83.16%110.24%31-74.17%32-63.64%
Sep 30, 2025104-55.93%8,585,305-72.26%180.42%45-65.91%47-33.80%
Jun 30, 2025237-2.47%32,613,359-1.94%691.43%13214.78%70-25.53%
Mar 31, 20255-98.12%1,063,934-97.00%20.04%3-97.50%2-98.02%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.16M4.86%564.00
FullerThaler Behavioral Small-Cap Equity1.34M2.95%46.67K
FullerThaler Behavioral Sm-Cp Eq R61.34M2.95%46.67K
FullerThaler Beh Small-Cap Equity SMA1.34M2.95%-
Vanguard Total Stock Mkt Idx Inv1.11M2.49%-
Vanguard US Total Market Shares ETF1.14M2.40%1.24K
TD U.S. Capital Reinvestment I981.53K2.16%-51.47K
Avantis US Small Cap Value ETF874.86K1.96%-
iShares Russell 2000 ETF844.94K1.90%7.14K
TD Epoch U.S. Quality Capital Reinvestmt770.52K1.73%-211.00K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 17, 2025Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$256.38K
Dec 12, 2025Petersen Floyd F.-Sell$62.89K
Dec 11, 2025Petersen Floyd F.-Sell$44.62K
Nov 25, 2025PRINS RICHARD K-Sell$113.25K
Nov 13, 2025Petersen Floyd F.-Sell$441.84K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4-7
2025 Q3-3
2025 Q2-3
2025 Q1-2

AMPH Ownership FAQ


Who Owns Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals shareholders are primarily institutional investors at 68.20%, followed by 29.63% insiders and 2.17% retail investors. The average institutional ownership in Amphastar Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Amphastar Pharmaceuticals exceeds.

Who owns the most shares of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals’s largest shareholders are Blackrock (5.94M shares, 12.33%), Blackrock funding, inc. /de (5.42M shares, 11.60%), and Vanguard group (2.61M shares, 5.61%). Together, they hold 29.54% of Amphastar Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amphastar Pharmaceuticals?

Yes, BlackRock owns 12.33% of Amphastar Pharmaceuticals, totaling 5.94M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.7M$. In the last quarter, BlackRock decreased its holdings by -137K shares, a -2.25% change.

Who is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bridge city capital is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.82% of its assets in 335.1K Amphastar Pharmaceuticals shares, valued at 6.56M$.

Who is the top mutual fund holder of Amphastar Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amphastar Pharmaceuticals shares, with 4.86% of its total shares outstanding invested in 2.16M Amphastar Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools